Business Segments · Selling, general, and administrative expense
Neuroscience — Selling, general, and administrative expense
Medtronic Neuroscience — Selling, general, and administrative expense decreased by 3.8% to $841.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 2.6%, from $820.00M to $841.00M. This is a positive signal — lower values indicate better performance for this metric.
Analysis
StatementSegment
CategoryEfficiency
SignalLower is better
VolatilityStable
First reportedQ1 2023
Last reportedQ1 2026
Rolls up toSG&A
How to read this metric
Rising expenses relative to sales may indicate increased competition or higher customer acquisition costs, while lower expenses relative to sales suggest improved operational leverage.
Detailed definition
This covers the costs of marketing, sales force compensation, legal, and administrative support functions dedicated to t...
Peer comparison
Comparable to SG&A expense ratios in the medical device sector.
Metric ID:
mdt_segment_neuroscience_selling_general_and_administrative_expenseHistorical Data
11 periods
| Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $547.25M | $547.25M | $547.25M | $547.25M | $808.00M | $834.00M | $820.00M | $885.00M | $831.00M | $874.00M | $841.00M |
| QoQ Change | — | +0.0% | +0.0% | +0.0% | +47.6% | +3.2% | -1.7% | +7.9% | -6.1% | +5.2% | -3.8% |
| YoY Change | — | — | — | — | +47.6% | +52.4% | — | — | +2.8% | +4.8% | +2.6% |
Range$547.25M – $885.00M
CAGR+18.8%
Avg YoY Growth+22.0%
Median YoY Growth+4.8%
Similar Metrics at Other Companies
Frequently Asked Questions
- What is Medtronic's neuroscience — selling, general, and administrative expense?
- Medtronic (MDT) reported neuroscience — selling, general, and administrative expense of $841.00M in Q1 2026.
- How has Medtronic's neuroscience — selling, general, and administrative expense changed year-over-year?
- Medtronic's neuroscience — selling, general, and administrative expense increased by 2.6% year-over-year, from $820.00M to $841.00M.
- What does neuroscience — selling, general, and administrative expense mean?
- The cost of selling, marketing, and managing the neuroscience business.